Press Release: Esperion : Esperion to Report First Quarter 2025 Financial Results on May 6
ANN ARBOR, Mich., April 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025.
Read full article »
Esperion is a Michigan-based pharmaceutical company that researches and develops oral therapies for the treatment of cardiovascular and cardiometabolic diseases.
Read more